Presentation Information

[29P-143]The fourth-generation EGFR inhibitor BLU-945 overcomes cancer multidrug resistance by inhibiting the drug efflux activity of ABCG2

○Chung-Pu Wu1,2,3,4, Bing-Huan Lin1, Yen-Ching Li1, Megumi Murakami5, Suresh V Ambudkar5 (1. Graduate Institute of Biomedical Sciences, Chang Gung University, 2. Department of Physiology and Pharmacology, Chang Gung University, 3. Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, 4. Molecular Medicine Research Center, College of Medicine, Chang Gung University, 5. Laboratory of Cell Biology, CCR, NCI, National Institutes of Health)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.